{
    "name": "vaccinia immune globulin intravenous",
    "comment": "Rx",
    "other_names": [
        "VIGIV"
    ],
    "classes": [
        "Immune Globulins"
    ],
    "source": "https://reference.medscape.com/drug/vigiv-vaccinia-immune-globulin-intravenous-343271",
    "pregnancy": {
        "common": [
            "There are no data on the use in pregnant females to inform on drug-associated risk ",
            "Animal reproduction studies have not been conducted "
        ],
        "specific": []
    },
    "lactation": {
        "common": []
    },
    "warnings": {
        "black_box_warning": {
            "common": [
                "Blood glucose measurement in patients receiving must be done with a glucose-specific method (monitor and test strips) to avoid interference by maltose contained in VIGIV ",
                "Maltose in IGIV products may give falsely high blood glucose levels in certain types of blood glucose testing systems (eg, text based on GDH-PQQ or glucose-dye-oxidoreductase methods) resulting in inappropriate administration of insulin and life-threatening hypoglycemia ",
                "Cases of true hypoglycemia may go untreated if hypoglycemic state is masked by falsely elevated glucose readings Carefully review blood glucose testing systems, including test strips, to determine if the system is appropriate for use with maltose-containing parenteral products "
            ],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to immunoglobulins",
                "Presence of isolated vaccinia keratitis",
                "IGA deficiency"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Severe, immediate hypersensitivity reactions to plasma-derived products may occur; administer in setting where appropriate equipment and personnel trained in management of acute anaphylaxis are available; discontinue immediately if hypotension, allergic, or anaphylactic reaction occurs ",
                "Renal dysfunction, acute renal failure, osmotic nephropathy, proximal tubular nephropathy, and death may occur with us of IGIV products; caution with renal insufficiency (including, but not limited to those with diabetes mellitus, age â‰¥65 yr, volume depletion, paraproteinemia, sepsis, coadministration of nephrotoxic drugs); contains 5% sucrose",
                "Some types of blood glucose testing systems (eg, test based on glucose dehydrogenase pyrroloquinolinequinone [GDH-PQQ] or glucose-dye-oxidoreductase methods) could falsely interpret the maltose contained in VIGIV as glucose; and therefore, result in falsely elevated glucose readings and unnecessary administration of insulin ",
                "Thrombotic events may occur; caution in patients at risk including history of cardiovascular risk factors, advanced age, impaired cardiac output, hypercoagulable disorders, prolonged periods of immobilization, history of arterial or venous thrombosis, estrogen use, indwelling central vascular catheters, and/or known or suspected hyperviscosity ",
                "May contain blood group antibodies which may act as hemolysins and induce in vivo coating of red blood cells with immune globulin, causing a positive direct antiglobulin reaction and hemolysis ",
                "Aseptic meningitis syndrome (AMS) may occur; AMS usually begins within several hours to 2 days following IGIV treatment; discontinuation of treatment has resulted in remission of AMS within several days without sequelae ",
                "Noncardiogenic pulmonary edema (transfusion-related acute lung injury [TRALI]) may occur; TRALI characterized by severe respiratory distress, pulmonary edema, hypoxemia, normal left ventricular function, and fever reported within 1-6 hr after transfusion ",
                "Derived from human plasma, small risk of viral transmission (eg, Creutzfeldt-Jakob disease) through administration "
            ],
            "specific": [
                {
                    "type": "Drug interaction overview ",
                    "description": [
                        "Defer immunization with live virus vaccine ~3 months after administration of VIGIV ",
                        "Revaccinate people (after 3 months) who received VIGIV shortly after a live virus vaccine ",
                        "Immune globulin may impair efficacy of live attenuated vaccines (eg, measles, rubella, mumps and varicella) "
                    ]
                }
            ]
        }
    },
    "interactions": [
        {
            "classification_type": "Serious",
            "interaction_with": "axicabtagene ciloleucel",
            "description": {
                "common": "vaccinia immune globulin intravenous, axicabtagene ciloleucel.\nEither increases effects of the other by immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "brexucabtagene autoleucel",
            "description": {
                "common": "vaccinia immune globulin intravenous, brexucabtagene autoleucel.\nEither increases effects of the other by immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "ciltacabtagene autoleucel",
            "description": {
                "common": "vaccinia immune globulin intravenous, ciltacabtagene autoleucel.\nEither increases effects of the other by immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "idecabtagene vicleucel",
            "description": {
                "common": "vaccinia immune globulin intravenous, idecabtagene vicleucel.\nEither increases effects of the other by immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "lisocabtagene maraleucel",
            "description": {
                "common": "vaccinia immune globulin intravenous, lisocabtagene maraleucel.\nEither increases effects of the other by immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "tisagenlecleucel",
            "description": {
                "common": "vaccinia immune globulin intravenous, tisagenlecleucel.\nEither increases effects of the other by immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "adenovirus types 4 and 7 live, oral",
            "description": {
                "common": "vaccinia immune globulin intravenous decreases effects of adenovirus types 4 and 7 live, oral by pharmacodynamic antagonism. Use Caution/Monitor. Defer live vaccines for 3 months after immune globulin administration."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "BCG vaccine live",
            "description": {
                "common": "vaccinia immune globulin intravenous decreases effects of BCG vaccine live by pharmacodynamic antagonism. Use Caution/Monitor. Defer live vaccines for 3 months after immune globulin administration."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "efgartigimod alfa",
            "description": {
                "common": "efgartigimod alfa will decrease the level or effect of vaccinia immune globulin intravenous by  receptor binding competition. Use Caution/Monitor. Coadministration of efgartigimod with medications that bind to the human neonatal Fc receptor may lower systemic exposures and effectiveness of such medications. Closely monitor for reduced effectiveness of medications that bind to the human neonatal Fc receptor. If long-term use of such medications is essential, consider discontinuing efgartigimod and using alternative therapies."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "measles mumps and rubella vaccine, live",
            "description": {
                "common": "vaccinia immune globulin intravenous decreases effects of measles mumps and rubella vaccine, live by pharmacodynamic antagonism. Use Caution/Monitor. Defer live vaccines for 3 months after immune globulin administration."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "measles, mumps, rubella and varicella vaccine, live",
            "description": {
                "common": "vaccinia immune globulin intravenous decreases effects of measles, mumps, rubella and varicella vaccine, live by pharmacodynamic antagonism. Use Caution/Monitor. Defer live vaccines for 3 months after immune globulin administration."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "rubella vaccine",
            "description": {
                "common": "vaccinia immune globulin intravenous decreases effects of rubella vaccine by pharmacodynamic antagonism. Use Caution/Monitor. Defer live vaccines for 3 months after immune globulin administration."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "smallpox (vaccinia) vaccine, live",
            "description": {
                "common": "vaccinia immune globulin intravenous decreases effects of smallpox (vaccinia) vaccine, live by pharmacodynamic antagonism. Use Caution/Monitor. Defer live vaccines for 3 months after immune globulin administration."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "varicella virus vaccine live",
            "description": {
                "common": "vaccinia immune globulin intravenous decreases effects of varicella virus vaccine live by pharmacodynamic antagonism. Use Caution/Monitor. Defer live vaccines for 3 months after immune globulin administration."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "protein a column",
            "description": {
                "common": "protein a column decreases levels of vaccinia immune globulin intravenous by Other (see comment). Minor/Significance Unknown. \nComment: Since Prosorba binds IgG, it could theoretically interfere with the levels and/or effects of pharmacologic immune globulins."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Headache",
            "percent": "54.8"
        },
        {
            "name": "Rigors",
            "percent": "22.6"
        },
        {
            "name": "Dizziness",
            "percent": "16.1"
        },
        {
            "name": "Feeling cold",
            "percent": "12.9"
        },
        {
            "name": "Nausea",
            "percent": "12.9"
        },
        {
            "name": "Headache",
            "percent": "59"
        },
        {
            "name": "Nausea",
            "percent": "28.2"
        },
        {
            "name": "Rigors",
            "percent": "17.9"
        },
        {
            "name": "Dizziness",
            "percent": "17.9"
        },
        {
            "name": "Feeling cold",
            "percent": "15.4"
        },
        {
            "name": "Pain",
            "percent": "12.8"
        },
        {
            "name": "Sweating increased",
            "percent": "9.7"
        },
        {
            "name": "Feeling hot",
            "percent": "9.7"
        },
        {
            "name": "Asthenia",
            "percent": "6.5"
        },
        {
            "name": "Pyrexia",
            "percent": "6.5"
        },
        {
            "name": "Appetite decreased",
            "percent": "6.5"
        },
        {
            "name": "Muscle spasm",
            "percent": "6.5"
        },
        {
            "name": "Back pain",
            "percent": "6.5"
        },
        {
            "name": "Paresthesia",
            "percent": "6.5"
        },
        {
            "name": "Vomiting",
            "percent": "3.2"
        },
        {
            "name": "Pain",
            "percent": "3.2"
        },
        {
            "name": "Tremor",
            "percent": "3.2"
        },
        {
            "name": "Pallor",
            "percent": "3.2"
        },
        {
            "name": "Vomiting",
            "percent": "7.7"
        },
        {
            "name": "Pallor",
            "percent": "7.7"
        },
        {
            "name": "Asthenia",
            "percent": "5.1"
        },
        {
            "name": "Fatigue",
            "percent": "5.1"
        },
        {
            "name": "Appetite decreased",
            "percent": "5.1"
        },
        {
            "name": "Muscle spasm",
            "percent": "5.1"
        },
        {
            "name": "Back pain",
            "percent": "5.1"
        },
        {
            "name": "Tremor",
            "percent": "5.1"
        },
        {
            "name": "Sweating increased",
            "percent": "5.1"
        },
        {
            "name": "Feeling hot",
            "percent": "2.6"
        },
        {
            "name": "Pyrexia",
            "percent": "2.6"
        },
        {
            "name": "Paresthesia",
            "percent": "2.6"
        },
        {
            "name": "Cardiovascular",
            "percent": null
        },
        {
            "name": "Cardiac arrest",
            "percent": null
        },
        {
            "name": "tachycardia",
            "percent": null
        },
        {
            "name": "Hematologic and lymphatic",
            "percent": null
        },
        {
            "name": "Neutropenia",
            "percent": null
        },
        {
            "name": "leukopenia",
            "percent": null
        },
        {
            "name": "anemia",
            "percent": null
        },
        {
            "name": "lymphadenopathy",
            "percent": null
        },
        {
            "name": "Integumentary",
            "percent": null
        },
        {
            "name": "Stevens",
            "percent": null
        },
        {
            "name": "Johnson syndrome",
            "percent": null
        },
        {
            "name": "epidermolysis",
            "percent": null
        },
        {
            "name": "erythema multiforme",
            "percent": null
        },
        {
            "name": "dermatitis",
            "percent": null
        },
        {
            "name": "eg",
            "percent": null
        },
        {
            "name": "bullous dermatitis",
            "percent": null
        },
        {
            "name": "urticaria or other skin reactions",
            "percent": null
        },
        {
            "name": "Gastrointestinal",
            "percent": null
        },
        {
            "name": "Hepatic dysfunction",
            "percent": null
        },
        {
            "name": "abdominal pain",
            "percent": null
        },
        {
            "name": "diarrhea",
            "percent": null
        },
        {
            "name": "Muscular",
            "percent": null
        },
        {
            "name": "Myalgia",
            "percent": null
        },
        {
            "name": "arthralgia",
            "percent": null
        },
        {
            "name": "Neurological",
            "percent": null
        },
        {
            "name": "Coma",
            "percent": null
        },
        {
            "name": "loss of consciousness",
            "percent": null
        },
        {
            "name": "seizures Renal",
            "percent": null
        },
        {
            "name": "Acute kidney injury",
            "percent": null
        },
        {
            "name": "osmotic nephropathy",
            "percent": null
        },
        {
            "name": "Respiratory",
            "percent": null
        },
        {
            "name": "Apnea",
            "percent": null
        },
        {
            "name": "Acute Respiratory Distress Syndrome",
            "percent": null
        },
        {
            "name": "ARDS",
            "percent": null
        },
        {
            "name": "cyanosis",
            "percent": null
        },
        {
            "name": "hypoxemia",
            "percent": null
        },
        {
            "name": "pulmonary edema",
            "percent": null
        },
        {
            "name": "dyspnea",
            "percent": null
        },
        {
            "name": "bronchospasm",
            "percent": null
        },
        {
            "name": "wheezing",
            "percent": null
        },
        {
            "name": "General",
            "percent": null
        },
        {
            "name": "body as a whole",
            "percent": null
        },
        {
            "name": "Malaise",
            "percent": null
        },
        {
            "name": "chest discomfort",
            "percent": null
        }
    ]
}